A 
4.69
-3.50%
Close of 9 Nov 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
At a glance
Figures in USD, from our data supplier.
Revenue
$586.3m
FY2019FY2025
Net income
$27.9m
FY2019FY2025
Free cash flow
−$114.7m
FY2019FY2025
Shareholders' equity
−$284.5m
FY2019FY2025
Income statement
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | |
|---|---|---|---|---|---|---|---|
| Revenue | $586.3m | $489.7m | $91.4m | $83.0m | $36.8m | $66.6m | $31.9m |
| Research and development | $184.2m | $171.3m | $210.8m | $180.6m | $191.0m | $148.1m | $95.6m |
| Operating income | $78.2m | $69.6m | −$517.9m | −$460.2m | −$235.5m | −$191.3m | −$61.4m |
| Net income | $27.9m | −$231.9m | −$551.7m | −$513.6m | −$101.5m | −$170.0m | −$209.9m |
| Diluted earnings per share | 0.10 | -0.77 | -2.07 | -2.07 | -3.25 | -5.44 | -0.86 |
Balance sheet
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | |
|---|---|---|---|---|---|---|---|
| Total assets | $1.49bn | $1.22bn | $950.1m | $828.4m | $598.0m | $474.4m | — |
| Cash and short-term investments | $172.4m | $51.4m | $11.2m | $66.4m | $17.6m | $31.7m | — |
| Total liabilities | $1.77bn | $1.63bn | $1.88bn | $1.39bn | $733.6m | $1.34bn | — |
| Debt | $1.45bn | $1.19bn | $1.08bn | $805.1m | $523.1m | $676.8m | — |
| Shareholders' equity | −$284.5m | −$412.8m | −$932.5m | −$564.4m | −$135.6m | −$867.2m | — |
| Shares outstanding | 279m | 302m | 267m | 249m | 31m | 31m | 244m |
Cash flow
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | |
|---|---|---|---|---|---|---|---|
| Cash from operations | −$50.2m | −$236.8m | −$312.2m | −$312.4m | −$228.2m | −$74.3m | −$88.5m |
| Capital spending | −$64.5m | −$57.0m | −$46.5m | −$49.0m | −$40.6m | −$12.0m | −$8.1m |
| Free cash flow | −$114.7m | −$293.8m | −$358.7m | −$361.4m | −$268.8m | −$86.3m | −$96.6m |
| Dividends paid | — | — | — | −$184.8m | — | — | — |
Latest quarters
By quarter end
| Jun 2026 | Mar 2026 | Dec 2025 | Sept 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sept 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $105.8m | $105.9m | $166.4m | $114.0m | $173.2m | $132.8m | $151.2m | $102.9m |
| Operating income | −$11.8m | $8.4m | $48.2m | $1.4m | $42.8m | $10.6m | $13.5m | $12.7m |
| Net income | −$66.8m | $1.0m | −$108.6m | −$5.2m | $32.0m | $109.7m | −$67.0m | −$11.4m |
| Diluted earnings per share | -0.19 | 0.00 | -0.39 | -0.02 | 0.11 | 0.39 | -0.22 | -0.04 |
| Cash from operations | −$19.0m | −$60.0m | −$62.0m | −$55.0m | $55.0m | $12.0m | −$39.0m | −$71.0m |
| Capital spending | −$27.0m | −$46.0m | −$8.0m | −$18.0m | −$13.0m | −$23.0m | −$31.0m | −$13.0m |
| Free cash flow | −$46.0m | −$106.0m | −$70.0m | −$73.0m | $42.0m | −$11.0m | −$70.0m | −$84.0m |
| Total assets | $1.59bn | $1.42bn | $1.49bn | $1.41bn | $1.39bn | $1.25bn | $1.22bn | $1.23bn |
| Cash and short-term investments | $142.8m | $63.8m | $172.4m | $42.8m | $151.5m | $38.5m | $51.4m | $118.3m |
| Debt | $53.8m | $1.32bn | $1.31bn | $1.14bn | $1.13bn | $1.11bn | $1.08bn | $1.04bn |
| Shareholders' equity | −$191.5m | −$282.3m | −$284.5m | −$176.8m | −$173.3m | −$302.3m | −$412.8m | −$343.7m |
Financial ratios
Data as of 5 Nov 2026
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | |
|---|---|---|---|---|---|---|
| Operating margin | 48.7% | -13.0% | -566.4% | -554.3% | -98.5% | -291.7% |
| Net margin | 4.8% | -47.3% | -603.4% | -618.6% | -276.0% | -255.3% |
| Return on equity | -9.8% | 56.2% | 59.2% | 91.0% | 74.8% | 19.6% |
| Return on assets | 1.9% | -19.0% | -58.1% | -62.0% | -17.0% | -35.8% |
| Free cash flow yield | 1.1% | -12.8% | -21.3% | -22.7% | -128.5% | -42.7% |
| Revenue growth | 19.7% | 435.6% | 10.1% | 125.8% | -44.8% | 108.7% |
| Earnings growth | -112.0% | -58.0% | 7.4% | 406.0% | -40.3% | -19.0% |
| Current ratio | 1.89x | 2.35x | 0.75x | 1.38x | 1.07x | 1.69x |
| Debt to equity | -4.61x | -2.61x | -1.04x | -1.36x | -3.01x | -0.66x |
| Equity ratio | -19.1% | -33.8% | -98.1% | -68.1% | -22.7% | -182.8% |
| Interest coverage | 1.91x | -0.40x | -3.84x | -5.03x | -0.32x | -1.99x |
| R&D as a share of sales | 31.4% | 35.0% | 230.6% | 217.5% | 519.4% | 222.3% |
| Buybacks as a share of market value | 7.5% | -13.1% | -7.3% | -695.7% | 0.0% | 87.2% |
Growth per year
Compound annual rate
| 3 years | 5 years | 10 years | |
|---|---|---|---|
| Revenue | 91.9% | 54.5% | — |
Average margins
Over each period
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Operating margin | 13.7% | -66.4% | -92.8% | — |
| Net margin | -19.0% | -101.5% | -113.8% | — |
Valuation history
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|
| Price to earnings | 51.3 | -17.2 | -5.5 | -4.8 |
| Price to sales | 2.4 | 8.2 | 33.5 | 29.9 |
Market value over time
30 Nov 2020 to 4 Nov 2026, in USD
$2.41bn$1.67bn
Share price return
Finished calendar years
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Return | -60% | 10% | 39% | -30% |
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.